A protein to treat multiple cancers

Israeli biotech Compugen announced that the protein CGEN-15022, discovered by the company, has the potential for treating liver, colorectal, lung and ovarian cancers through monoclonal antibody (mAb) therapy.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *